
Lupin shares gain after USFDA nod, launch of generic Sugammadex Injection for neuromuscular blockade reversal
Lupin said its product is bioequivalent to Merck’s Bridion Injection and is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium…








